Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - lamotrigine - טבליות הניתנות לפיזור\לעיסה - lamotrigine 25 mg - lamotrigine - lamotrigine - epilepsy : monotherapy in adults and children over 12 years of age: simple partial seizures. complex partial seizures. generalised tonic clonic secondarily seizures. primary generalised tonic clonic seisures. add- on therapy in adults and children over 2 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seizures. adults (18 years of age and over) lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder, predominantly by preventing depressive episodes.

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - lamotrigine - טבליות הניתנות לפיזור\לעיסה - lamotrigine 100 mg - lamotrigine - lamotrigine - epilepsy: monotherapy in adults and children over 12 years of age: 1. simple partial seizures. 2. complex partial seizures. 3. generalised tonic clonic secondarily seizures. 4. primary generalised tonic clonic seizures. add-on therapy in adults and children over 2 years of age: 1. simple partial seizures. 2. complex partial seizures. 3. secondarily generalised tonic clonic seizures. adults (18 years of age and over) lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - lamotrigine - טבליות הניתנות לפיזור\לעיסה - lamotrigine 200 mg - lamotrigine - lamotrigine - epilepsy: monotherapy in adults and children over 12 years of age: 1. simple partial seizures. 2. complex partial seizures. 3. generalised tonic clonic secondarily seizures. 4. primary generalised tonic clonic secondarily seizures. add-on therapy in adults and children over 2 years of age: 1. simple partial seizures. 2. complex partial seizures. 3. secondarily generalised tonic clonic seizures. adults (18 years of age and over) lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - albendazole - טבליה - albendazole 400 mg - albendazole - albendazole - treatment of hydatid cysts caused by echinococcosus granulosus or e. multilocularis.eskazole may be used as first-line medical therapy in patients with hydatid disease or as an adjunct to surgery, either pre- or postoperatively.

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - salbutamol as sulfate - אבקה לשאיפה - salbutamol as sulfate 200 mcg/dose - salbutamol - salbutamol - relief of bronchospasm in broncial asthma of all types, chronic, bronchitis and emphysema.

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - salbutamol as sulfate - תמיסה להזרקה - salbutamol as sulfate 0.5 mg/ml - salbutamol - salbutamol - for relief of severe bronchospasm associated with asthma and bronchitis status asthmaticus.

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - clavulanic acid as potassium salt 11.4 mg/ml; amoxicillin as trihydrate 80 mg/ml - amoxicillin and enzyme inhibitor

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - טבליות מצופות פילם - amoxicillin as trihydrate 875 mg; clavulanic acid as potassium salt 125 mg - ampicillin and enzyme inhibitor

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - neisseria meningitides group b strain nz98/254; neisseria meningitidis group b fhbp fusion protein; neisseria meningitidis group b nada protein; neisseria meningitidis group b nhba fusion protein - תרחיף להזרקה - neisseria meningitides group b strain nz98/254 25 mcg; neisseria meningitidis group b fhbp fusion protein 50 mcg; neisseria meningitidis group b nada protein 50 mcg; neisseria meningitidis group b nhba fusion protein 50 mcg - meningococcus b, outer membrane vesicle vaccine

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - תרחיף להזרקה - b/phuket/3073/2013 (b/yamagata lineage)-like virus 30 mcg ha / 1 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 30 mcg ha / 1 ml; a/darwin/9/2021 (h3n2)-like virus 30 mcg ha / 1 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 30 mcg ha / 1 ml - influenza, inactivated, split virus or surface antigen